These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23735701)

  • 1. Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects measured by cardiopulmonary exercise testing.
    Armstrong HF; Thirapatarapong W; Dussault NE; Bartels MN
    Respiration; 2013; 86(5):407-13. PubMed ID: 23735701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.
    Armstrong HF; Schulze PC; Bacchetta M; Thirapatarapong W; Bartels MN
    Respirology; 2014 Jul; 19(5):675-82. PubMed ID: 24797365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular response patterns during exercise in interstitial lung disease.
    Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
    Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of end-tidal CO
    Higashi A; Dohi Y; Yamabe S; Kinoshita H; Sada Y; Kitagawa T; Hidaka T; Kurisu S; Yamamoto H; Yasunobu Y; Kihara Y
    Heart Vessels; 2017 Nov; 32(11):1350-1357. PubMed ID: 28560485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-expired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases.
    Hansen JE; Ulubay G; Chow BF; Sun XG; Wasserman K
    Chest; 2007 Sep; 132(3):977-83. PubMed ID: 17573506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography.
    Held M; Grün M; Holl R; Hübner G; Kaiser R; Karl S; Kolb M; Schäfers HJ; Wilkens H; Jany B
    Respiration; 2014; 87(5):379-87. PubMed ID: 24732343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
    Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
    Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
    Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
    J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension].
    Blanco I; Villaquirán C; Valera JL; Molina-Molina M; Xaubet A; Rodríguez-Roisin R; Barberà JA; Roca J
    Arch Bronconeumol; 2010 Mar; 46(3):122-8. PubMed ID: 20138698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
    Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension.
    Yasunobu Y; Oudiz RJ; Sun XG; Hansen JE; Wasserman K
    Chest; 2005 May; 127(5):1637-46. PubMed ID: 15888840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in chronic obstructive and interstitial lung diseases.
    Andersen CU; Mellemkjær S; Nielsen-Kudsk JE; Bendstrup E; Hilberg O; Simonsen U
    Int J Cardiol; 2013 Oct; 168(3):1795-804. PubMed ID: 23849967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
    Bernstein EJ; Gordon JK; Spiera RF; Huang WT; Horn EM; Mandl LA
    Rheumatology (Oxford); 2017 Jan; 56(1):87-94. PubMed ID: 28028158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension secondary to interstitial lung disease.
    Shlobin OA; Nathan SD
    Expert Rev Respir Med; 2011 Apr; 5(2):179-89. PubMed ID: 21510729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.
    Oliveira RKF; Waxman AB; Hoover PJ; Dellaripa PF; Systrom DM
    Chest; 2020 Jul; 158(1):350-358. PubMed ID: 32173491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in interstitial lung disease.
    Behr J; Ryu JH
    Eur Respir J; 2008 Jun; 31(6):1357-67. PubMed ID: 18515559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiopulmonary exercise testing in exercise-induced pulmonary hypertension].
    Chenivesse C; Rachenne V; Fournier C; Leroy S; Nevière R; Le Tourneau T; Wallaert B
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):141-8. PubMed ID: 16788438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.